|
1
|
Williamson JM, Thorn CC, Spalding D and
Williamson RC: Pancreatic and peripancreatic somatostatinomas. Ann
R Coll Surg Engl. 93:356–360. 2011.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zakaria A, Hammad N, Vakhariya C and
Raphael M: Somatostatinoma presented as double-duct sign. Case Rep
Gastrointest Med. 2019(9506405)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wiesli P, Pavlicek V, Brändle M,
Pfammatter T, Perren A and Schmid C: Distinct mechanisms of
hypoglycaemia in patients with somatostatin-secreting
neuroendocrine tumours. Endocrinol Diabetes Metab.
2(e00083)2019.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Thavaraputta S, Graham S, Rivas Mejia AM
and Lado-Abeal J: Duodenal somatostatinoma presenting as
obstructive jaundice with the coexistence of a gastrointestinal
stromal tumour in neurofibromatosis type 1: A case with review of
the literature. BMJ Case Rep. 12(bcr-2018-226702)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ambrose T, Stephenson TJ, Booth J and
Chandra N: Case report: Recurrent acute pancreatitis secondary to
papillary somatostatinoma - a new association. Pancreatology.
13:186–188. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gheorghisan-Galateanu AA, Carsote M and
Valea A: Incidentaloma: From general practice to specific endocrine
frame. J Pak Med Assoc. 67:917–922. 2017.PubMed/NCBI
|
|
7
|
French JB and Pawa R: Somatostatinoma of
the Ampulla: An incidental postoperative finding following
colorectal cancer resection. ACG Case Rep J. 3:109–111.
2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Koc O, Duzkoylu Y, Sari YS, Bektas H, Uzum
G, Tunali V and Pasaoglu E: Duodenal somatostatinoma: A case report
and review of the literature. J Med Case Rep. 7(115)2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kanakis G and Kaltsas G: Biochemical
markers for gastroenteropancreatic neuroendocrine tumours
(GEP-NETs). Best Pract Res Clin Gastroenterol. 26:791–802.
2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Choe J, Kim KW, Kim HJ, Kim DW, Kim KP,
Hong SM, Ryu JS, Tirumani SH, Krajewski K and Ramaiya N: What is
new in the 2017 World Health Organization Classification and 8th
American Joint Committee on cancer staging system for pancreatic
neuroendocrine neoplasms? Korean J Radiol. 20:5–17. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ito T, Igarashi H and Jensen RT:
Pancreatic neuroendocrine tumors: clinical features, diagnosis and
medical treatment: advances. Best Pract Res Clin Gastroenterol.
26:737–753. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
de Herder WW, Rehfeld JF, Kidd M and
Modlin IM: A short history of neuroendocrine tumours and their
peptide hormones. Best Pract Res Clin Endocrinol Metab. 30:3–17.
2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
de Wilde RF, Edil BH, Hruban RH and Maitra
A: Well-differentiated pancreatic neuroendocrine tumors: From
genetics to therapy. Nat Rev Gastroenterol Hepatol. 9:199–208.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ishida H and Lam AK: Pancreatic
neuroendocrine neoplasms: The latest surgical and medical treatment
strategies based on the current World Health Organization
classification. Crit Rev Oncol Hematol. 145(102835)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Corleto VD: Somatostatin and the
gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes.
17:63–68. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Arrojo E, Drigo R, Jacob S, García-Prieto
CF, Zheng X, Fukuda M, Nhu HT, Stelmashenko O, Peçanha FL,
Rodriguez-Diaz R, Bushong E, et al: Structural basis for delta cell
paracrine regulation in pancreatic islets. Nat Commun.
10(3700)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Stengel A and Taché Y: Central
somatostatin signaling and regulation of food intake. Ann NY Acad
Sci. 1455:98–104. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Dumitrascu MC, Stanescu AM, Bejan C,
Sandru F, Toader DO, Radavoi DG, Cotirlet A, Pusta CT and Diaconu
CC: Obesity and its implications on stress urinary incontinence.
Rev Chim (Bucharerst). 70:3660–3662. 2019.
|
|
19
|
Silaghi AC, Poantă L, Valea A, Pais R and
Silaghi H: Is epicardial adipose tissue, assessed by
echocardiography, a reliable method for visceral adipose tissue
prediction? Med Ultrason. 13:15–20. 2011.PubMed/NCBI
|
|
20
|
Srivastava G and Apovian C: Future
pharmacotherapy for obesity: New anti-obesity drugs on the horizon.
Curr Obes Rep. 7:147–161. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mansour JC and Chen H: Pancreatic
endocrine tumors. J Surg Res. 120:139–161. 2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Mozell E, Stenzel P, Woltering EA, Rösch J
and O'Dorisio TM: Functional endocrine tumors of the pancreas:
Clinical presentation, diagnosis, and treatment. Curr Probl Surg.
27:301–386. 1990.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Nesi G, Marcucci T, Rubio CA, Brandi ML
and Tonelli F: Somatostatinoma: Clinico-pathological features of
three cases and literature reviewed. J Gastroenterol Hepatol.
23:521–526. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Prachayakul V, Aswakul P, Deesomsak M and
Pongpaibul A: Gastric somatostatinoma: An extremely rare cause of
upper gastrointestinal bleeding. Clin Endosc. 46:582–585.
2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Därr R, Nambuba J, Del Rivero J, Janssen
I, Merino M, Todorovic M, Balint B, Jochmanova I, Prchal JT, Lechan
RM, et al: Novel insights into the
polycythemia-paraganglioma-somatostatinoma syndrome. Endocr Relat
Cancer. 23:899–908. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Janssen I, Chen CC, Zhuang Z, Millo CM,
Wolf KI, Ling A, Lin FI, Adams KT, Herscovitch P, Feelders RA, et
al: Functional imaging signature of patients presenting with
polycythemia/paraganglioma syndromes. J Nucl Med. 58:1236–1242.
2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jochmanova I and Lazurova I: A new twist
in neuroendocrine tumor research: Pacak-Zhuang syndrome, HIF-2α as
the major player in its pathogenesis and future therapeutic
options. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.
158:175–180. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang H, Cui J, Yang C, Rosenblum JS, Zhang
Q, Song Q, Pang Y, Fang F, Sun M, Dmitriev P, et al: A transgenic
mouse model of Pacak-Zhuang syndrome with an Epas1 gain-of-function
mutation. Cancers (Basel). 11(2019)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Pang Y, Gupta G, Jha A, Yue X, Wang H,
Huynh TT, Li A, Li L, Baker E, Chew E, et al: Nonmosaic somatic
HIF2A mutations associated with late onset
polycythemia-paraganglioma syndrome: Newly recognized subclass of
polycythemia-paraganglioma syndrome. Cancer. 125:1258–1266.
2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vianna PM, Ferreira CR and de Campos FP:
Somatostatinoma syndrome: A challenging differential diagnosis
among pancreatic tumors. Autops Case Rep. 3:29–37. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kim JA, Choi WH, Kim CN, Moon YS, Chang SH
and Lee HR: Duodenal somatostatinoma: A case report and review.
Korean J Intern Med. 26:103–107. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Brelian D and Tenner S: Diarrhoea due to
pancreatic diseases. Best Pract Res Clin Gastroenterol. 26:623–631.
2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jara Letelier DI, Bonotto ML and Ardengh
JC: Somatostatinoma of the minor duodenal papilla associated with
pancreas divisum treated by endoscopic papillectomy. Endoscopy. 48
(Suppl 1):E135–E137. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Albulescu DM, Carsote M, Ionovici N,
Ghemigian A, Popescu M, Tuculina MJ, Dascalu IT, Preda SA, Tirca T,
Petrescu MS, et al: 5-Hydroxytriptamine and skeleton influence
Clinical study. Rev Chim (Bucharest). 69:2438–2442. 2018.PubMed/NCBI
|
|
35
|
Walczyk J and Sowa-Staszczak A: Diagnostic
imaging of gastrointestinal neuroendocrine neoplasms with a focus
on ultrasound. J Ultrason. 19:228–235. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Poiană C, Neamţu MC, Avramescu ET, Carşote
M, Trifănescu R, Terzea D, Neamţu OM, Ferechide D and Dănciulescu
Miulescu R: The poor prognosis factors in G2 neuroendocrine tumor.
Rom J Morphol Embryol. 54 (Suppl 3):717–720. 2013.PubMed/NCBI
|
|
37
|
Carşote M, Păun S, Neamţu MC, Avramescu
ET, Iosif C, Terzea D, Constantinoiu S, Dănciulescu Miulescu R,
Neamţu OM and Poiană C: The immunohistochemistry aspects in two
cases of neurofibromatosis-associated abdominal tumors. Rom J
Morphol Embryol. 53:401–405. 2012.PubMed/NCBI
|
|
38
|
Chan H, Moseley C, Zhang L, Bergsland EK,
Pampaloni MH, Van Loon K and Hope TA: Correlation of DOTATOC uptake
and pathologic grade in neuroendocrine tumors. Pancreas.
48:948–952. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Przybylik-Mazurek E, Palen J,
Pasternak-Pietrzak K, Sowa-Staszczak A, Brzozowska-Czarnek A and
Hubalewska-Dydejczyk A: Coexistence of neurofibromatosis type 1
with multiple malignant neoplasia. Neuro Endocrinol Lett.
39:149–155. 2018.PubMed/NCBI
|
|
40
|
Reynolds R and Marjoniemi V: Mixed
mucinous adenocarcinoma and somatostatinoma of the ampulla of Vater
associated with neurofibromatosis type 1. Pathology. 49:553–555.
2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Philpott C, Tovell H, Frayling IM, Cooper
DN and Upadhyaya M: The NF1 somatic mutational landscape in
sporadic human cancers. Hum Genomics. 11(13)2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Hernández-Martín A and Duat-Rodríguez A:
An update on neurofibromatosis type 1: Not just café-au-lait spots
and freckling. Part II. Other skin manifestations characteristic of
NF1. NF1 and cancer. Actas Dermosifiliogr. 107:465–473.
2016.PubMed/NCBI View Article : Google Scholar : (In English and
Spanish).
|
|
43
|
Rozza-de-Menezes RE, Brum CA, Gaglionone
NC, de Sousa Almeida LM, Andrade-Losso RM, Paiva BV, Faveret PL, da
Silva AV, Siqueira OH, Riccardi VM, et al: Prevalence and
clinicopathological characteristics of lipomatous neurofibromas in
neurofibromatosis 1: An investigation of 229 cutaneous
neurofibromas and a systematic review of the literature. J Cutan
Pathol. 45:743–753. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Lutterodt CG, Mohan A and Kirkpatrick N:
The use of electrodessication in the treatment of cutaneous
neurofibromatosis: A retrospective patient satisfaction outcome
assessment. J Plast Reconstr Aesthet Surg. 69:765–769.
2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Afşar CU, Kara IO, Kozat BK, Demiryürek H,
Duman BB and Doran F: Neurofibromatosis type 1, gastrointestinal
stromal tumor, leiomyosarcoma and osteosarcoma: Four cases of rare
tumors and a review of the literature. Crit Rev Oncol Hematol.
86:191–199. 2013.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Anderson JL and Gutmann DH:
Neurofibromatosis type 1. Handb Clin Neurol. 132:75–86.
2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Thomas AK, Egelhoff JC, Curran JG and
Thomas B: Pediatric schwannomatosis, a rare but distinct form of
neurofibromatosis. Pediatr Radiol. 46:430–435. 2016.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Evans DG: Neurofibromatosis type 2. Handb
Clin Neurol. 132:87–96. 2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Ardern-Holmes S, Fisher G and North K:
Neurofibromatosis Type 2. J Child Neurol. 32:9–22. 2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Yamamoto R, Kato S, Maru T, Ninomiya R,
Ozawa F, Beck Y, Abe K, Tamaru J, Nagoshi S and Yakabi K: The
coexistence of somatostatinoma and gastrointestinal stromal tumor
in the duodenum of a patient with Von Recklinghausen's disease.
Intern Med. 55:617–622. 2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Njei B and Sanchez H: Education and
imaging Gastrointestinal: Neurofibromatosis type 1, duodenal
somatostatinoma and gastrointestinal stromal tumors; a triad worth
remembering. J Gastroenterol Hepatol. 29(663)2014.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Hiesgen J and Variava E: Neuroendocrine
tumour in a patient with neurofibromatosis type 1 and HIV. South
Afr J HIV Med. 16(323)2015.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Bhandari R, Riddiough G, Lokan J, Weinberg
L, Efthymiou M and Nikfarjam M: Somatostatinoma of the minor
papilla treated by local excision in a patient with
neurofibromatosis type 1. JOP. 16:81–84. 2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Tewari N, Rollins K, Gandhi N, Kaye P and
Lobo DN: Mixed periampullary adenocarcinoma and somatostatinoma
with small bowel gastrointestinal stromal tumour in
neurofibromatosis type 1. JOP. 15:600–603. 2014.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Xie R, Fu KI, Chen SM, Tuo BG and Wu HC:
Neurofibromatosis type 1-associated multiple rectal neuroendocrine
tumors: A case report and review of the literature. World J
Gastroenterol. 24:3806–3812. 2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Constantinoiu S, Constantin A, Predescu D,
Iosif C, Hoara P, Achim F, Surugiu P, Bacanu F and Cociu L:
Somatostatinoma of the first jejunal loop in a patient with
neurofibromatosis von Recklinghausen and bilateral
pheochromocytoma. Hepatogastroenterology. 59:1874–1878.
2012.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Pan D, Liang P and Xiao H:
Neurofibromatosis type 1 associated with pheochromocytoma and
gastrointestinal stromal tumors: A case report and literature
review. Oncol Lett. 12:637–643. 2016.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Cimino PJ and Gutmann DH:
Neurofibromatosis type 1. Handb Clin Neurol. 148:799–811.
2018.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Bundschuh RA, Habacha B, Lütje S and
Essler M: Therapy of patients with neuroendocrine
neoplasia-evidence-based approaches and new horizons. J Clin Med.
8(E1474)2019.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Huang PY, Tsai KL, Liang CM, Tai WC, Rau
KM, Wu KL, Huang CC and Chuah SK: Prognostic factors of patients
with gastroenteropancreatic neuroendocrine neoplasms. Kaohsiung J
Med Sci. 34:650–656. 2018.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Poiană C, Neamţu MC, Avramescu ET, Carşote
M, Trifănescu R, Terzea D, Neamţu OM and Dănciulescu Miulescu R:
The dedifferentiation of neuroendocrine tumor metastases: Myth or
reality? Rom J Morphol Embryol. 54:201–203. 2013.PubMed/NCBI
|
|
62
|
Poiană C, Carşote M, Neamţu MC, Avramescu
ET, Vasilescu F, Terzea D, Păun D, Trifănescu R and Dănciulescu
Miulescu R: Well-differentiated neuroendocrine tumor and
osteoporosis: Incidental findings? Rom J Morphol Embryol.
54:1169–1171. 2013.PubMed/NCBI
|
|
63
|
Untch BR, Bonner KP, Roggin KK,
Reidy-Lagunes D, Klimstra DS, Schattner MA, Fong Y, Allen PJ,
D'Angelica MI, DeMatteo RP, et al: Pathologic grade and tumor size
are associated with recurrence-free survival in patients with
duodenal neuroendocrine tumors. J Gastrointest Surg. 18:457–462;
discussion 462-463. 2014.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Guilmette J and Nosé V: Paraneoplastic
syndromes and other systemic disorders associated with
neuroendocrine neoplasms. Semin Diagn Pathol. 36:229–239.
2019.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Paun DL, Vija L, Stan E, Banica A, Bobeica
E, Terzea D, Poiana C, Badiu C and Paun S: Cushing syndrome
secondary to ectopic adrenocorticotropic hormone secretion from a
Meckel diverticulum neuroendocrine tumor: Case report. BMC Endocr
Disord. 15(72)2015.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Pasmant E, Parfait B, Luscan A, Goussard
P, Briand-Suleau A, Laurendeau I, Fouveaut C, Leroy C, Montadert A,
Wolkenstein P, et al: Neurofibromatosis type 1 molecular diagnosis:
What can NGS do for you when you have a large gene with loss of
function mutations? Eur J Hum Genet. 23:596–601. 2015.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Wu-Chou YH, Hung TC, Lin YT, Cheng HW, Lin
JL, Lin CH, Yu CC, Chen KT, Yeh TH and Chen YR: Genetic diagnosis
of neurofibromatosis type 1: Targeted next-generation sequencing
with multiple ligation-dependent probe amplification analysis. J
Biomed Sci. 25(72)2018.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Xu G, Li M, Niu Y, Huang X, Li Y, Tang G,
Long S, Zhao H and Jiang H: Identification of a novel NF1
frameshift variant in a Chinese family with neurofibromatosis type
1. BioMed Res Int. 2019(2721357)2019.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Yap YS, Munusamy P, Lim C, Chan CH,
Prawira A, Loke SY, Lim SH, Ong KW, Yong WS, Ng SB, et al: Breast
cancer in women with neurofibromatosis type 1 (NF1): A
comprehensive case series with molecular insights into its
aggressive phenotype. Breast Cancer Res Treat. 171:719–735.
2018.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Solomon I, Voiculescu VM, Caruntu C, Lupu
M, Popa A, Ilie MA, Albulescu R, Caruntu A, Tanase C, Constantin C,
et al: Neuroendocrine factors and head and neck squamous cell
carcinoma: An affair to remember. Dis Markers.
2018(9787831)2018.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Ion A, Popa IM, Papagheorghe LM, Lisievici
C, Lupu M, Voiculescu V, Caruntu C and Boda D: Proteomic approaches
to biomarker discovery in cutaneous T-cell lymphoma. Dis Markers.
2016(9602472)2016.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Boda D: Cellomics as integrative omics for
cancer. Curr Proteomics. 10:237–245. 2013.
|
|
73
|
Ilie MA, Caruntu C, Lupu M, Lixandru D,
Tampa M, Georgescu SR, Bastian A, Constantin C, Neagu M, Zurac SA,
et al: Current and future applications of confocal laser scanning
microscopy imaging in skin oncology. Oncol Lett. 17:4102–4111.
2019.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Căruntu C, Boda D, Guţu DE and Căruntu A:
In vivo reflectance confocal microscopy of basal cell carcinoma
with cystic degeneration. Rom J Morphol Embryol. 55:1437–1441.
2014.PubMed/NCBI
|
